237 related articles for article (PubMed ID: 32209474)
1. Chromatin Remodeling and Immediate Early Gene Activation by SLFN11 in Response to Replication Stress.
Murai J; Zhang H; Pongor L; Tang SW; Jo U; Moribe F; Ma Y; Tomita M; Pommier Y
Cell Rep; 2020 Mar; 30(12):4137-4151.e6. PubMed ID: 32209474
[TBL] [Abstract][Full Text] [Related]
2. SLFN11 Blocks Stressed Replication Forks Independently of ATR.
Murai J; Tang SW; Leo E; Baechler SA; Redon CE; Zhang H; Al Abo M; Rajapakse VN; Nakamura E; Jenkins LMM; Aladjem MI; Pommier Y
Mol Cell; 2018 Feb; 69(3):371-384.e6. PubMed ID: 29395061
[TBL] [Abstract][Full Text] [Related]
3. SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.
Jo U; Murai Y; Chakka S; Chen L; Cheng K; Murai J; Saha LK; Miller Jenkins LM; Pommier Y
Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536335
[TBL] [Abstract][Full Text] [Related]
4. Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents.
Zoppoli G; Regairaz M; Leo E; Reinhold WC; Varma S; Ballestrero A; Doroshow JH; Pommier Y
Proc Natl Acad Sci U S A; 2012 Sep; 109(37):15030-5. PubMed ID: 22927417
[TBL] [Abstract][Full Text] [Related]
5. Schlafen 11 (SLFN11), a restriction factor for replicative stress induced by DNA-targeting anti-cancer therapies.
Murai J; Thomas A; Miettinen M; Pommier Y
Pharmacol Ther; 2019 Sep; 201():94-102. PubMed ID: 31128155
[TBL] [Abstract][Full Text] [Related]
6. The SWI/SNF Chromatin Regulator BRG1 Modulates the Transcriptional Regulatory Activity of the Epstein-Barr Virus DNA Polymerase Processivity Factor BMRF1.
Su MT; Wang YT; Chen YJ; Lin SF; Tsai CH; Chen MR
J Virol; 2017 May; 91(9):. PubMed ID: 28228591
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of BLM, dissociation from topoisomerase IIIalpha, and colocalization with gamma-H2AX after topoisomerase I-induced replication damage.
Rao VA; Fan AM; Meng L; Doe CF; North PS; Hickson ID; Pommier Y
Mol Cell Biol; 2005 Oct; 25(20):8925-37. PubMed ID: 16199871
[TBL] [Abstract][Full Text] [Related]
8. BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
Coussy F; El-Botty R; Château-Joubert S; Dahmani A; Montaudon E; Leboucher S; Morisset L; Painsec P; Sourd L; Huguet L; Nemati F; Servely JL; Larcher T; Vacher S; Briaux A; Reyes C; La Rosa P; Lucotte G; Popova T; Foidart P; Sounni NE; Noel A; Decaudin D; Fuhrmann L; Salomon A; Reyal F; Mueller C; Ter Brugge P; Jonkers J; Poupon MF; Stern MH; Bièche I; Pommier Y; Marangoni E
Sci Transl Med; 2020 Feb; 12(531):. PubMed ID: 32075943
[TBL] [Abstract][Full Text] [Related]
9. SLFN11 Is a Transcriptional Target of EWS-FLI1 and a Determinant of Drug Response in Ewing Sarcoma.
Tang SW; Bilke S; Cao L; Murai J; Sousa FG; Yamade M; Rajapakse V; Varma S; Helman LJ; Khan J; Meltzer PS; Pommier Y
Clin Cancer Res; 2015 Sep; 21(18):4184-93. PubMed ID: 25779942
[TBL] [Abstract][Full Text] [Related]
10. Schlafen 11 (SLFN11) Kills Cancer Cells Undergoing Unscheduled Re-replication.
Murai J; Ceribelli M; Fu H; Redon CE; Jo U; Murai Y; Aladjem MI; Thomas CJ; Pommier Y
Mol Cancer Ther; 2023 Aug; 22(8):985-995. PubMed ID: 37216280
[TBL] [Abstract][Full Text] [Related]
11. BRG1, the ATPase subunit of SWI/SNF chromatin remodeling complex, interacts with HDAC2 to modulate telomerase expression in human cancer cells.
Wu S; Ge Y; Huang L; Liu H; Xue Y; Zhao Y
Cell Cycle; 2014; 13(18):2869-78. PubMed ID: 25486475
[TBL] [Abstract][Full Text] [Related]
12. Schlafen-11 sensitizes colorectal carcinoma cells to irinotecan.
Tian L; Song S; Liu X; Wang Y; Xu X; Hu Y; Xu J
Anticancer Drugs; 2014 Nov; 25(10):1175-81. PubMed ID: 25089570
[TBL] [Abstract][Full Text] [Related]
13. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
Demidova AR; Aau MY; Zhuang L; Yu Q
J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
[TBL] [Abstract][Full Text] [Related]
14. Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition.
Murai J; Feng Y; Yu GK; Ru Y; Tang SW; Shen Y; Pommier Y
Oncotarget; 2016 Nov; 7(47):76534-76550. PubMed ID: 27708213
[TBL] [Abstract][Full Text] [Related]
15. Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 (
Tang SW; Thomas A; Murai J; Trepel JB; Bates SE; Rajapakse VN; Pommier Y
Clin Cancer Res; 2018 Apr; 24(8):1944-1953. PubMed ID: 29391350
[No Abstract] [Full Text] [Related]
16. Chromatin remodeling factor CHR18 interacts with replication protein RPA1A to regulate the DNA replication stress response in Arabidopsis.
Han JJ; Song ZT; Sun JL; Yang ZT; Xian MJ; Wang S; Sun L; Liu JX
New Phytol; 2018 Oct; 220(2):476-487. PubMed ID: 29974976
[TBL] [Abstract][Full Text] [Related]
17. High-Resolution 4C Reveals Rapid p53-Dependent Chromatin Reorganization of the CDKN1A Locus in Response to Stress.
Millau JF; Wijchers P; Gaudreau L
PLoS One; 2016; 11(10):e0163885. PubMed ID: 27741251
[TBL] [Abstract][Full Text] [Related]
18. Decarbamoyl mitomycin C (DMC) activates p53-independent ataxia telangiectasia and rad3 related protein (ATR) chromatin eviction.
Xiao G; Kue P; Bhosle R; Bargonetti J
Cell Cycle; 2015; 14(5):744-54. PubMed ID: 25565400
[TBL] [Abstract][Full Text] [Related]
19. Inducible expression of immediate early genes is regulated through dynamic chromatin association by NF45/ILF2 and NF90/NF110/ILF3.
Wu TH; Shi L; Lowe AW; Nicolls MR; Kao PN
PLoS One; 2019; 14(4):e0216042. PubMed ID: 31022259
[TBL] [Abstract][Full Text] [Related]
20. The ribonuclease domain function is dispensable for SLFN11 to mediate cell fate decision during replication stress response.
Qi F; Alvi E; Ogawa M; Kobayashi J; Mu A; Takata M
Genes Cells; 2023 Sep; 28(9):663-673. PubMed ID: 37469008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
